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        Infl  ammatory bowel diseases (IBDs) comprise a 
spectrum of immune-mediated conditions in 
which the target organ is the intestine. IBD is 
divided into two primary forms, Crohn  ’  s dis-
ease and ulcerative colitis (  1  ). Although the eti-
ology remains unknown, increasing evidence 
suggests that IBD is the result of a dysregulated 
mucosal infl  ammatory response (  2  ). TNF is a 
particularly important contributor to intestinal 
infl  ammation, and blockade of TNF with anti-
TNF antibodies is an eff  ective treatment for a 
subset of Crohn  ’  s disease patients (  3  ). Several 
lines of evidence point to the TNF-related cyto-
kine LIGHT (homologous to lymphotoxin, 
shows inducible expression, and competes with 
HSV glycoprotein D for herpes virus entry 
mediator [HVEM], a receptor expressed by T 
lymphocytes) as another important mediator of 
mucosal infl   ammation and IBD pathogenesis 
(  4  –  6  ). Activated T cells and immature DCs ex-
press LIGHT, and it has been described as a 
proinfl  ammatory cytokine and a potent T cell 
co-stimulatory molecule (  7  –  10  ). Mature Th1-
type CD4  +   T cells and mucosal T cells isolated 
from patients with IBD express high levels of 
LIGHT (  4  ). Furthermore, transgenic mice with 
T cells constitutively expressing LIGHT devel-
oped spontaneous multi-organ infl  ammation 
that included the intestine (  11, 12  ), and intesti-
nal infl  ammation could be induced by transfer 
of LIGHT transgenic T cells (  13  ). 
  LIGHT signals via two members of the 
TNF receptor super family, the lymphotoxin      
receptor, predominantly expressed by myeloid 
lineage, stromal, and epithelial cells (  14  –  17  ), 
and the HVEM, broadly expressed by hemato-
poietic cells as well as by some somatic cells 
(  18  –  21  ). LIGHT-mediated IBD pathogenesis 
in mice has been attributed to its interaction 
with both of these receptors (  6  ). Whereas the 
interaction of LIGHT with lymphotoxin      re-
ceptor is thought to induce transformations in 
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    The interaction between the tumor necrosis factor (TNF) family member LIGHT and the TNF 
family receptor herpes virus entry mediator (HVEM) co-stimulates T cells and promotes 
infl  ammation. However, HVEM also triggers inhibitory signals by acting as a ligand that 
binds to B and T lymphocyte attenuator (BTLA), an immunoglobulin super family member. 
The contribution of HVEM interacting with these two binding partners in infl  ammatory 
processes remains unknown. In this study, we investigated the role of HVEM in the develop-
ment of colitis induced by the transfer of CD4  +  CD45RB  high   T cells into recombination acti-
vating gene (  Rag  )        /        mice. Although the absence of HVEM on the donor T cells led to a 
slight decrease in pathogenesis, surprisingly, the absence of HVEM in the   Rag      /        recipients 
led to the opposite effect, a dramatic acceleration of intestinal infl  ammation. Furthermore, 
the critical role of HVEM in preventing colitis acceleration mainly involved HVEM ex-
pression by radioresistant cells in the   Rag      /        recipients interacting with BTLA. Our experi-
ments emphasize the antiinfl  ammatory role of HVEM and the importance of HVEM 
expression by innate immune cells in preventing runaway infl  ammation in the intestine. 1464 HVEM  –  BTLA INTERACTION PREVENTS INTESTINAL INFLAMMATION   | Steinberg et al. 
the adoptive transfer of CD4  +  CD45RB  high   naive T cells, de-
pleted of CD25  +   regulatory T cells, into syngeneic   Rag      /        
mice. This leads to a progressive disease, with weight loss and 
colitis appearing 5  –  10 wk after the transfer (  33  ). To evaluate 
if the expression of HVEM in T cells is required for colitis 
induction, we transferred CD4  +  CD45RB  high   T cells isolated 
from   Hvem      /        or WT mice into   Rag      /        recipients. As ex-
pected, WT donor CD4  +  CD45RB  high   T cells induced a 
gradual weight loss in   Rag      /        recipients that correlated 
with disease progression, as did the transfer of   Hvem      /        
CD4  +  CD45RB  high   T cells (  Fig. 1 A  ).   Although at early time 
points after the transfer weight loss in the   Rag      /        recipient mice 
of   Hvem      /        T cells was slightly less pronounced, the recipients 
the gut mucosa that alter the normal microenvironment of 
the intestine, its binding with HVEM expressed by T cells 
promotes T cell activation and the T cell expansion required 
for the full development of disease (  6  ). In other contexts, en-
gagement of HVEM by LIGHT delivers co-stimulatory sig-
nals leading to T cell activation (  8, 9, 18, 22  ) and enhanced 
T cell  –  mediated immunity (  11, 12, 19, 23, 24  ). Furthermore, 
it has been described that engagement of HVEM by LIGHT 
induced activation of human mucosal T cells and increased 
IFN-     release (  4  ). Therefore, it appears that HVEM may 
contribute to IBD pathogenesis by promoting T cell activa-
tion and Th1 responses (  4, 6  ). 
  It has been recently discovered, however, that HVEM 
can also deliver inhibitory signals to T cells (  25, 26  ). These 
inhibitory signals involve a receptor that binds HVEM, a 
member of the Ig super family called B and T lymphocyte at-
tenuator (BTLA) (  25  ). Once engaged by HVEM, the ITIM 
motifs in the cytoplasmic tail of BTLA become tyrosine 
phosphorylated, allowing the recruitment of the phosphatases 
SHP-1 and SHP-2 (  27, 28  ). Recent studies have shown that 
HVEM- as well as BTLA-defi  cient T cells are hyperrespon-
sive to TCR-induced stimulation in vitro (  26  –  28  ). Addition-
ally, both HVEM- and BTLA-defi  cient mice presented a 
higher susceptibility to experimental autoimmune encepha-
lomyelitis (  26, 28  ), whereas the loss of BTLA dramatically 
accelerated partially MHC-mismatched cardiac allograft 
rejection (  29  ) and prolonged airway inflammation (  30  ). 
Furthermore, the BTLA  –  HVEM interaction limited T 
cell activity in vivo, negatively regulating the homeostatic 
expansion of a subset of CD8  +   memory T cells (  31  ). De-
spite its generally inhibitory role, BTLA has recently been 
reported to play a role in promoting the survival of T cells 
activated during a mouse model of graft versus host disease 
(GVHD) (  32  ). 
  Therefore, whereas some evidence indicates that HVEM 
is the co-stimulatory receptor responsible for LIGHT-medi-
ated T cell activation, other data demonstrate that HVEM 
can be a negative regulator of T cell responses by triggering 
BTLA-derived inhibitory signals. The actual contribution of 
HVEM to T cell  –  mediated immune responses, and to the 
pathogenesis of T cell  –  mediated infl  ammatory conditions 
such as IBD, remains to be determined. Moreover, most of 
the studies that investigate the role of HVEM binding to its 
ligands have emphasized the expression of one or more of 
these molecules by B and T lymphocytes, and their roles in 
directly regulating lymphocyte responses. In this study, we 
investigated the role of HVEM and its binding partners 
in the development of colitis induced by the transfer of 
CD4  +  CD45RB  high   T cells into   Rag      /        mice, and the possible 
function of HVEM in cells of the innate immune system that 
are present in the   Rag      /        hosts. 
    RESULTS   
  The role of HVEM expression by T cells in colitis induction 
  To investigate the participation of HVEM in colitis patho-
genesis, we used an experimental mouse model initiated by 
    Figure 1.         CD4  +  CD45RB  high   T cells do not require HVEM to induce 
colitis.   (A) Weight loss curves of   Rag    /      recipients transferred with 
5   ×   10 5   CD4 + CD45RB high   T cells isolated from either WT C57BL/6 mice 
(open squares) or   Hvem    /      mice  (fi  lled squares). The graph shows the 
average weight loss as a percentage of the initial weight of four mice in 
each group, and they are representative of four independent experiments. 
(B) H  &  E staining of proximal and distal colon of   Rag    /      mice  transferred 
with WT or   Hvem    /      T cells. The histological scores of the representative 
sections shown are indicated (bottom right of each panel). GC, goblet 
cells. (C) Average scores of the proximal and distal colon sections were 
evaluated 12 wk after the transfer of T cells. Sections of the large intes-
tine isolated from different recipients were microscopically analyzed as 
described in Materials and methods. Each square represents a single 
mouse (eight per group). *, P   <   0.05.     JEM VOL. 205, June 9, 2008 
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  Accelerated colitis in   Hvem      /     Rag      /        recipients 
  HVEM expression is not restricted to T cells, and therefore 
to evaluate if HVEM expressed by non  –  T cells participates 
in colitis pathogenesis, we bred HVEM-defi  cient   Rag      /        
(  Hvem      /     Rag      /       ) animals to use as recipients.   Hvem      /     Rag      /        
recipients that were transferred with WT CD4  +  CD45RB  high   
T cells exhibited a surprising acceleration of weight loss and 
colitis, as determined by the presence of diarrhea and other 
clinical signs, such as reduced mobility and piloerection of 
the fur. Notably, recipient   Hvem      /     Rag      /        mice showed a 
reduction of     20% of their initial starting weight only 2 wk 
after transfer (  Fig. 2 A  ).   The intestinal infl  ammation in these 
recipients was progressive and lethal, and in most cases the 
recipients did not survive beyond 3  –  4 wk after transfer. This 
accelerated infl  ammation was confi  ned, however, predomi-
nantly to the large intestine (not depicted). Conversely, in 
the same brief period,   Rag      /        recipients did not show any 
weight loss (  Fig. 2 A  ). In addition to the faster weight loss, 
transferred   Hvem      /     Rag      /        mice presented early evidence of 
unquestionably became ill, eventually all the transferred 
  Rag      /        recipients showed an equivalent weight loss (  Fig. 1 A  ), 
and the overall diff  erence between   Hvem      /        and WT donor 
T cells did not reach statistical signifi  cance. Microscopic anal-
ysis of hematoxylin and eosin (H  &  E)-stained tissue sections 
obtained from the large intestine of transferred mice revealed 
severe infl  ammation in all of the recipients. However, mice 
transferred with   Hvem      /        T cells had lower mononuclear cell 
infi  ltrates in the proximal and distal colon. In addition, these 
recipients had a higher number of goblet cells in the distal 
colon, indicating that infl   ammation in these animals was 
milder (  Fig. 1 B  ). Scoring of sections obtained from the 
recipients transferred with   Hvem      /        T cells showed a lower 
average histological score than in the animals that received 
WT T cells (  Fig. 1 C  ). Overall, these results suggest that 
HVEM expression on donor T cells contributed to a limited 
extent to increasing intestinal infl  ammation; however, HVEM 
expression in T cells was not absolutely required for coli-
tis development. 
    Figure 2.         Colitis acceleration in   Hvem      /     Rag      /        mice.   Transfer of CD4  + CD45RB high   T cells into   Hvem    /   Rag   /      mice dramatically accelerated colitis. 
(A) Weight loss curves of   Rag    /      (squares) and   Hvem    /   Rag   /      (circles) recipients of 5   ×   10  5   WT T cells showed an extremely rapid disease progression in 
  Hvem    /   Rag   /      animals. Data correspond to the average of fi  ve mice per group and are representative of fi  ve independent experiments. (B) H  & E  staining 
of proximal and distal colon sections are shown. (C) Average scores of the proximal and distal colon sections from individual mice were evaluated 2 wk 
after the transfer of T cells. Each symbol represents an individual mouse (  n   = 5), and representative data from four experiments are shown. **, P   <   0.005. 
(D) Weight loss comparison after transfer of WT (open circles) or   Hvem    /      (fi  lled circles) CD4  + CD45RB high   T cells into   Hvem    /   Rag   /      recipients  ( n   =  6 – 7). 
(E) Combined proximal and distal histological analysis of colon sections performed 2 wk after the transfers described in part D. Each symbol represents an 
individual mouse (  n   =  7).   1466 HVEM  –  BTLA INTERACTION PREVENTS INTESTINAL INFLAMMATION   | Steinberg et al. 
ter transfer, intraepithelial CD4  +   TCR-      +   cell numbers in 
  Hvem      /     Rag      /        mice were 10-fold higher (P   <   0.005) (  Fig. 
3 B  ). Accordingly, the number of CD4  +   TCR-      +   lamina 
propria lymphocytes (LPLs) was also signifi  cantly higher in 
  Hvem      /     Rag      /        recipients at 2 wk (  Fig. 3 B  ). Collectively, 
these results demonstrate that the absence of HVEM in the 
  Rag      /        mice led to a more rapid accumulation of transferred 
T cells in the MLNs and large intestine. 
  Increased T cell cytokine production 
in   Hvem      /     Rag      /        recipients 
  To further characterize the colitis acceleration observed in 
  Hvem      /     Rag      /        mice, we investigated the profile of cyto-
kines produced in the large intestine of the recipient animals. 
2 wk after transfer, total mRNA was purifi  ed from the colon 
and subjected to RT-PCR analysis for several cytokines. 
RT-PCR revealed the presence of TNF and IFN-     mRNAs, 
and lower levels of IL-17 mRNA (  Fig. 3 C  ). Notably, the 
amount of mRNA for these cytokines, and in particular 
for TNF, was considerably higher in samples isolated from 
  Hvem      /     Rag      /        mice (  Fig. 3 C  ). The higher level of pro-
infl  ammatory cytokines in the intestine of   Hvem      /     Rag      /        
animals correlated with the rapid and severe intestinal infl  am-
mation observed. It should be noted that increased mRNA 
for TGF-     and IL-10 in the   Hvem      /     Rag      /        mice was also 
observed when compared with   Rag      /        recipients. The in-
creased presence of these antiinfl  ammatory cytokine mRNAs 
in the   Hvem      /     Rag      /        recipients could refl  ect a compensa-
tory regulatory mechanism in the face of infl  ammation, al-
though the amount of IL-10 mRNA was very low in all the 
samples (  Fig. 3 D  ). The amount of mRNA for IL-12 family 
cytokines in the colon was not very great, but in accord with 
the higher levels of IFN-     mRNA observed in   Hvem      /     Rag      /        
mice, we also detected an increase in IL-12 mRNA in the 
colon of these animals (  Fig. 3 E  ). The level of mRNA for IL-23, 
however, was equivalent in both   Rag      /        and   Hvem      /     Rag      /        
mice (  Fig. 3 E  ). 
  To determine if the transferred T cells had the capacity 
to produce proinfl  ammatory cytokines in the colon of the 
  Hvem      /     Rag      /        recipient mice, we evaluated cytokine pro-
duction by donor-derived LPLs restimulated in vitro. LPLs 
were purifi  ed from the large intestine of   Rag      /        or   Hvem      /    
Rag      /        recipient mice, stimulated with PMA, and ionomy-
cin, and 48 h later cytokines were determined by ELISA. 
The amounts of IFN-    , TNF, and IL-2 in the culture super-
natants of cells obtained from   Hvem      /     Rag      /        mice were 
considerably higher than those secreted by cells isolated from 
  Rag      /        recipients (  Fig. 3 F  ). Rather than an increased capacity 
to produce cytokines, the higher amounts of cytokines in the 
cultures of cells isolated from   Hvem      /     Rag      /        mice could have 
been due to the increased number of T cells in the LPL prep-
arations. Indeed, the percentage of CD4  +   TCR-      +   within 
the LPL suspension isolated from   Hvem      /     Rag      /        mice was 
about twofold higher than that observed in   Rag      /        animals 
(not depicted). The increment in cytokines in the isolated LPLs 
from   Hvem      /     Rag      /        mice was increased more than twofold, 
severe intestinal infl  ammation. Examination of H  &  E-stained 
sections obtained from   Hvem      /     Rag      /        recipients revealed 
prominent epithelial cell hyperplasia, absence of goblet cells, 
and a massive infi  ltration of mononuclear cells in the colons 
of these animals (  Fig. 2 B  ). Histological analysis performed on 
samples isolated from large intestine of these recipients 2 wk 
after transfer had an average pathology score of 8.8   ±   2.2 out 
of a possible of 14 (  Fig. 2 C  ). Samples from   Rag      /        recipients 
at the same early time after transfer showed almost intact epi-
thelial crypts with absence of epithelial cell hyperplasia and 
only few mononuclear cell infi  ltrates (  Fig. 2 B  ). The average 
score for samples obtained from the transferred   Rag      /        mice 
at this time was only 0.8   ±   1.0 (  Fig. 2 C  ). 
  We transferred  Hvem      /        donor T cells into  Hvem      /     Rag      /        
mice to analyze the situation in which HVEM is entirely miss-
ing. Interestingly, induced colitis and wasting disease in the 
completely HVEM-defi  cient situation were still accelerated 
compared with transfers to   Rag      /        animals. Weight loss in 
  Hvem      /     Rag      /        mice transferred with HVEM-defi  cient  T 
cells was equally accelerated compared with the same recipi-
ents transferred with WT T cells (  Fig. 2 D  ). Histological scores 
in these recipients completely lacking HVEM were also equiv-
alent to those observed in   Hvem      /     Rag      /        animals transferred 
with WT T cells (  Fig. 2 E  ). Overall, these results demonstrate 
that the absence of HVEM expression in   Rag      /        host cells led 
to a dramatic acceleration of colitis, and they show that this 
dramatic eff  ect was dominant over any deceleration of disease 
caused by the absence of HVEM expression by donor T cells. 
  Rapid accumulation of T cells in the large intestine 
of   Hvem      /     Rag      /        recipients 
  To characterize the colitis acceleration observed in   Hvem      /    
Rag      /        mice, we investigated the fate of the transferred T 
cells. We determined the number of CD4  +   T lymphocytes in 
the spleens and mesenteric lymph nodes (MLNs) of trans-
ferred mice, two sites where T cells expand dramatically after 
transfer to immune-defi  cient hosts (  34, 35  ). 1 wk after trans-
fer, the number of CD4  +   T cells in the MLNs of   Hvem      /    
Rag      /        animals was approximately threefold higher than in 
  Rag      /        mice (  Fig. 3 A  ).   This diff  erence was highly signifi  cant 
(P = 0.005). The number of T cells in the spleens of   Hvem      /    
Rag      /        mice was also slightly higher than in   Rag      /        recipi-
ents, although not statistically signifi  cant (  Fig. 3 A  ). Elevated 
numbers of T cells in the MLNs of   Hvem      /     Rag      /        animals 
were only observed at early time points after the transfer, and 
by 2 wk after transfer, the number of CD4  +   TCR-      +   lym-
phocytes in the MLNs was essentially equivalent in both re-
cipients (  Fig. 3 B  ). To investigate if the early accumulation of 
transferred T cells in inductive sites such as MLNs in the 
  Hvem      /     Rag      /        mice also aff  ected the target organ, we as-
sessed the accumulation of CD4  +   TCR-      +   T cells in the 
large intestine of the recipients. As early as 7 d after transfer, 
T lymphocytes were detectable in the large intestine. At this 
time, the average number of CD4  +   TCR-      +   cells infi  ltrating 
the epithelium of the   Hvem      /     Rag      /        mice was 2.3-fold 
higher than in   Rag      /        mice (  Fig. 3 A  ). However, by 2 wk af-JEM VOL. 205, June 9, 2008 
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CD11c  +   cells freshly isolated from the MLNs of the two 
types of mice expressed equivalent levels of the co-stimula-
tory molecules CD86 and CD80, suggesting that the DC 
maturation state was not greatly aff  ected by the absence of 
HVEM (Fig. S1 A). To determine if the threshold for stimu-
lation for DCs is altered in the absence of HVEM, CD11c  +   
cells from MLNs were stimulated with LPS. Upon stimula-
tion, both WT and   Hvem      /        DCs expressed similar levels of 
CD40 and CD86 (Fig. S1 B). Moreover, after LPS stimula-
tion, the percentage of WT and   Hvem      /        MLN DCs express-
ing IL-12 was essentially equivalent (Fig. S1 B). Collectively, 
these results demonstrate that the absence of HVEM in DCs 
did not signifi  cantly aff  ect their percentage, maturation state, 
or their capacity to secrete cytokines. For priming naive CD4  +   
T cells, freshly isolated DCs from the MLNs of   Hvem      /        
mice were slightly more eff  ective than their WT counter-
parts (proliferation indices of 2.6 and 2.1, respectively), 
although splenic DCs from these mice were not diff  erent 
from WT mice (Fig. S1 C). Likewise MLN DCs from mice 
defi  cient for the HVEM ligand BTLA did not prime more 
however, suggesting that increased proinfl  ammatory cytokines 
in the LPLs of these recipients could be due to a combina-
tion of increased cell number and increased eff  ectors. Col-
lectively, these fi  ndings suggest that the presence of increased 
CD4  +   T cells secreting high amounts of proinfl  ammatory cy-
tokines in the intestine of   Hvem      /     Rag      /        recipients contrib-
uted to the more rapid development of colitis. 
  DCs were not greatly affected in   Hvem      /        mice 
  Previous reports have suggested a role for HVEM in DC 
maturation and cytokine production (  36, 37  ), and therefore 
the absence of HVEM expression on DCs in the   Rag      /        re-
cipients might cause an abnormal development and/or func-
tion of these cells. In WT or   Hvem      /        mice, however, the 
percentage of DCs in the spleens and MLNs was essentially 
equivalent, and the two major subsets of DCs, those express-
ing high levels of CD11c and CD8    , and those expressing 
CD11b, were similarly represented in the MLNs of WT and 
  Hvem      /        animals (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20071160/DC1, and not depicted). 
    Figure 3.         Increased T cells and cytokines in   Hvem      /     Rag      /        recipients.   The number of CD4  +   TCR-   +   cells in the spleens, MLNs, and large intestines 
of recipient mice was assessed at the indicated times. (A) 1 wk after transfer,   Rag    /      (squares) and   Hvem    /   Rag   /      (circles) mice, four in each group, 
were analyzed by fl  ow cytometry for T cells in the spleens, large IELs, and MLNs. (B) Shows same as in A, but including LPLs and analyzed 2 wk after trans-
fer. Each symbol represents an individual mouse with a total of 7  –  10 mice per group. *, P   <   0.05; **, P   <   0.005. (C  –  E) Real-time PCR performed on tissue 
samples isolated from the large intestines of individual   Rag    /      (fi  lled bars) or   Hvem    /   Rag   /      (open bars) recipients 2 wk after transfer. Error bars repre-
sent SD of triplicate measurements. (F) LPLs isolated from transferred   Hvem    /   Rag   /      (open bars) and   Rag     /     (fi  lled bars) recipients at 2 wk were stimu-
lated ex vivo with PMA and ionomycin. After 48 h, cytokines in the supernatant were measured by ELISA.     1468 HVEM  –  BTLA INTERACTION PREVENTS INTESTINAL INFLAMMATION   | Steinberg et al. 
given   Hvem      /     Rag      /        BM cells (  Hvem      /     Rag      /         →    Rag      /       ) 
(  Fig. 4 A  ).   To verify that the chimeric mice were properly 
reconstituted, 8 wk after BM transplantation HVEM ex-
pression in peripheral blood cells from these animals was 
monitored. As expected, blood cells isolated from   Hvem      /    
Rag      /         →    Rag      /        mice expressing the hematopoietic lineage 
marker CD45 did not have detectable surface HVEM, indi-
cating reconstitution by the   Hvem      /        donor BM cells (  Fig. 4 B  ). 
In contrast, in   Rag      /         →    Hvem      /     Rag      /        chimeric mice the 
vast majority of the hematopoietic cells expressed intermedi-
ate or high levels of HVEM, indicating that they derived 
from the   Hvem  +/+     donors (  Fig. 4 B  ). A similar degree of re-
constitution was observed when organs containing immune 
cells from the chimeras were analyzed (not depicted). 
  Surprisingly, the transfer of CD4  +  CD45RB  high   T cells 
into   Rag      /         →    Hvem      /     Rag      /        chimeric recipients induced a 
eff  ectively (Fig. S1 C). In summary, HVEM defi  ciency did 
not grossly alter DCs, and the small increase in proliferation 
of naive T cells stimulated with   Hvem      /        DCs from MLNs is 
unlikely to account by itself for the accelerated T cell expan-
sion and colitis pathogenesis in   Hvem      /        recipients. 
  HVEM expression in radioresistant cells is required 
to prevent colitis acceleration 
  Because there was not an obvious APC defect in the   Hvem      /        
mice, to begin to identify the critical cell type(s) that must 
express HVEM, we analyzed chimeric   Rag      /        recipient mice 
that expressed HVEM only in irradiation-resistant cells, or 
only in cells derived from BM progenitors. To construct the 
chimeras, after lethal irradiation,   Hvem      /     Rag      /        mice were 
reconstituted with  Rag      /        BM cells ( Rag      /         →    Hvem      /     Rag      /       ), 
and reciprocal chimeras were constructed in   Rag      /        mice 
    Figure 4.         HVEM expression by radioresistant   Rag      /        cells prevents colitis acceleration.   (A) Experimental design. Lethally irradiated 
  Hvem    /   Rag   /      mice were transplanted with   Rag    /      BM cells to generate   Rag    /     →  Hvem    /   Rag   /      chimeric mice. Reciprocal   Hvem    /   Rag   /     →  Rag    /     
chimeras also were generated. 10 wk after transplant, chimeric mice were used as recipients of CD4  + CD45RB high   T cells. (B) Analysis of reconstitution. HVEM 
expression in peripheral blood cells of the chimeric animals was assessed 8 wk after BM cell transplant by fl  ow cytometry analysis for HVEM expression 
by CD45  +   cells. Open histograms represent HVEM staining, and fi  lled histograms represent the isotype control. Representative data are shown from one 
of many similar analyses of blood cells and cells from immune organs. (C) Transfer of 5   ×   10  5   CD4 + CD45RB high   T cells into   Hvem    /   Rag   /     →  Rag    /     
(squares) and   Rag    /     →  Hvem    /   Rag   /      (gray circles) chimeric recipients. Weight loss curves correspond to the average of six to eight chimeric mice per 
group. (D) Histological scores were determined 2 wk after transfer. Each symbol represents a single mouse of a total of seven   Hvem    /   Rag   /     →  Rag    /     
(squares) and eight   Rag    /     →  Hvem    /   Rag   /      (circles) chimeric mice. **, P   <   0.005. Data shown are representative from one of two independent experiments.   JEM VOL. 205, June 9, 2008 
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  Rag      /        animals and accelerated development of disease. We 
therefore performed transfer experiments using   Light      /        do-
nor T cells. The results showed similar weight loss in   Rag      /        
mice transferred with either   Light      /        or WT CD4  +  CD45RB  high   
T cells (  Fig. 5 A  ).   However, histological analysis performed 
in samples obtained from the large intestine of   Rag      /        recipi-
ents 12 wk after the transfer revealed lower levels of infl  am-
mation in animals transferred with   Light      /        T cells (  Fig. 5 B  ). 
This is consistent with other data indicating that LIGHT is a 
co-stimulatory molecule for T lymphocytes. Because the 
outcome after transfer of   Light      /        T cells was opposite to the 
results after transfer to   Hvem      /     Rag      /        recipients, we con-
clude that the accelerating eff  ects of host HVEM defi  ciency 
were not due to the absence of interactions with LIGHT ex-
pressed by the donor T cells. 
  Importantly, the transfer of   Light      /        CD4  +  CD45RB  high   
T cells into   Hvem      /     Rag      /        recipients induced a dramatic 
acceleration of weight loss (  Fig. 5 C  ) and colitis progression 
assessed by the presence of diarrhea and other clinical signs. The 
disease acceleration was similar to that observed in   Hvem      /    
Rag      /        mice transferred with WT T cells. Furthermore, the 
histological scores obtained with samples isolated from these 
  Hvem      /     Rag      /        animals 2 wk after the transfer showed 
equivalent levels of intestinal infl  ammation, regardless of the 
presence of LIGHT expression by the donor T cells (  Fig. 5 D  ). 
rapidly developing disease (  Fig. 4 C  ). Similar to the intact 
  Hvem      /     Rag      /        mice,   Rag      /         →    Hvem      /     Rag      /        recipients 
lost   >  20% of their initial weight by 2 wk after T cell transfer. 
Conversely,   Hvem      /     Rag      /         →    Rag      /        chimeric recipients 
that received CD4  +  CD45RB  high   T lymphocytes did not lose 
body weight in the same period of time (  Fig. 4 C  ). Consis-
tent with the diff  erence in weight loss, histological scoring 
performed in large intestine samples collected from the trans-
ferred chimeric recipients revealed a more severe infl  amma-
tion and tissue damage in   Rag      /         →    Hvem      /     Rag      /        mice 
than in the   Hvem      /     Rag      /         →    Rag      /        recipients (average 
score = 10.4   ±   2.0 in   Rag      /         →    Hvem      /     Rag      /        animals as 
opposed to 0.3   ±   0.5 in   Hvem      /     Rag      /         →    Rag      /        mice) 
(  Fig. 4 D  ). These results indicate that HVEM prevents colitis 
acceleration principally when expressed by radioresistant cells 
in the   Rag      /        hosts. 
  A radiation-resistant cell that might prevent accelerated 
infl  ammation through HVEM expression is the intestinal ep-
ithelial cell (IEC). In fact, human epithelial carcinoma cell 
lines (not depicted) and freshly isolated mouse colonic epi-
thelial cells express HVEM (Fig. S2 A, available at http://
www.jem.org/cgi/content/full/jem.20071160/DC1). A fea-
ture of IBD, in particular Crohn  ’  s disease, is increased in-
testinal permeability arising from a defect in the intestinal 
epithelium. Permeability to D-[1-  14  C]-mannitol therefore was 
measured across tissues from proximal and distal large intes-
tine, as well as the cecum, which were stripped of underlying 
smooth muscle and mounted in Ussing chambers. Although 
the trend was toward increased permeability in the distal colon 
of   Hvem      /        mice, the diff  erence was not signifi  cant when 
compared with WT tissues. However, permeability in the 
distal colon of both WT and   Hvem        /      mice was signifi  cantly 
lower than that observed in infl  amed tissues isolated from 
WT mice with colitis that had been induced by dextran so-
dium sulfate (DSS) (Fig. S2 B). Similar to the results from the 
distal large intestine, permeability in the proximal colon and 
cecum of WT and   Hvem        /      animals was essentially equiva-
lent (not depicted). Therefore, epithelial permeability is not 
compromised under noninfl  ammatory conditions in the ab-
sence of HVEM expression. Colitis induced by DSS repre-
sents a well-established epithelial injury model of intestinal 
infl  ammation.   Hvem      /        mice also displayed no increase in 
susceptibility to DSS-induced colitis when compared with 
WT mice (Fig. S3, A and B). 
  Effects of HVEM ligand expression by T cells 
  An appealing hypothesis for explaining the accelerated colitis 
in   Hvem      /     Rag      /        recipients is that enhanced disease is caused 
by the absence of an interaction between HVEM expressed 
by a cell type in the   Rag      /        recipients with an HVEM binding 
partner expressed by the donor T cells. Recent publications 
have suggested that expression of LIGHT by T cells is able to 
regulate innate immune responses by interacting with the 
HVEM receptor (  36, 38  –  41  ). Therefore, the absence of inter-
actions between T cell  –  derived LIGHT and HVEM on host 
cells might lead to a dysregulated innate immune response in 
    Figure 5.           Light      /        T cells do not cause accelerated colitis.   (A)  Weight 
loss curves of   Rag    /      recipients transferred with either WT (open squares) 
or   Light    /      CD4 + CD45RB high   T cells (open diamonds). The graph shows the 
average of four mice per group and is representative of one of three inde-
pendent experiments. (B) Average histological scores were evaluated 
12 wk after T cell transfer. Each square represents a single mouse of a 
total of six to seven mice in each group. *, P   <   0.05. (C) Results from the 
transfer of either WT (open circles) or   Light    /      (fi  lled circles) T cells into 
  Hvem    /   Rag   /      mice. Data shown correspond to the average weight loss 
of six mice per group. (D) Average histological scores analyzed 2 wk after 
WT or   Light    /      CD4 + CD45RB high   T cell transfer to   Hvem    /   Rag   /      animals. 
Each circle represents a single mouse in a total of six mice per group.     1470 HVEM  –  BTLA INTERACTION PREVENTS INTESTINAL INFLAMMATION   | Steinberg et al. 
also reduced (mean fl  uorescence intensity = 7,456 for LPL vs. 
mean fl   uorescence intensity = 26,183 for MLNs). Surpris-
ingly, although BTLA is an inhibitory receptor,   Btla      /        T cells 
transferred into   Rag      /        animals induced colitis similar to WT 
donors when weight loss was measured (  Fig. 6 C  ). Histologi-
cal analysis performed 2 wk after transfer revealed higher aver-
age scores for recipients transferred with   Btla        /      T cells, but 
there was no diff  erence at 5 wk (  Fig. 6 D  ). 
  Reduced number of BTLA-defi  cient T cells 
in   Rag        /      recipients 
  It has been recently shown that BTLA plays a role in the sur-
vival of T cells activated in a mouse GVHD model (  32  ). In 
light of our fi  nding that   Rag        /      recipients of BTLA-defi  cient 
T cells did not develop accelerated colitis, we hypothesized 
that BTLA-defi  cient T cells transferred into   Rag        /      recipients 
might have a survival defect, leading to a reduced number of 
eff  ector T cells that ultimately might aff  ect the onset of colitis. 
To address this possibility, we performed cotransfers of equal 
numbers of WT CD45.1  +   congenic and   Btla        /      CD45.2  +   
CD4  +  CD45RB  high   T cells into   Rag        /      recipients.   Btla        /      T 
cells did not accumulate as much as WT cells. The percent-
ages (  Fig. 7 A  ) and absolute numbers (  Fig. 7 B  ) of CD45.1  +   
CD4  +   TCR-      +   cells in the spleens, MLNs, LPLs, and intesti-
nal epithelial lymphocytes (IELs) were considerably higher 
than those for   Btla        /      (CD45.1       ) T cells 2 wk after transfer.   
Although the   Btla        /      T cells did not accumulate as much as 
WT donors, the BTLA-defi  cient T cells in   Rag        /      mice were 
capable of secreting proinfl  ammatory cytokines to a similar 
extent (  Fig. 7 C  ). Based on these fi  ndings, we hypothesize 
that transfer of   Btla        /      T cells did not recapitulate the results 
in   Hvem      /     Rag      /        recipients in part because the lower num-
bers of eff  ector T cells prevented disease acceleration. 
  Signaling through BTLA prevented colitis acceleration 
  To further explore the role of the BTLA inhibitory recep-
tor, we evaluated colitis development in recipient   Hvem      /    
Rag      /        mice treated with an anti-BTLA mAb (clone 6F7). 
When added to T cell  –  APC co-cultures stimulated with an 
anti-CD3     antibody, the 6F7 antibody attenuated T cell re-
sponses. The expression of CD25 and the production of IL-2 
by anti-BTLA  –  treated T cells were reduced compared with 
the IgG-treated control (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20071160/DC1). Importantly, 
the inhibitory eff  ect on immune responses mediated by the 
6F7 antibody was specifi  c to BTLA-expressing T cells, as the 
activation and proliferation of   Btla      /        T cells was essentially 
equivalent in cultures treated with the 6F7 mAb or an irrelevant 
IgG control (Fig. S4 B). The anti-BTLA mAb reduced IL-2 
and CD25 induction even when   Hvem      /        T cells and APCs 
were co-cultured (Fig. S4 D), indicating that the mAb acts di-
rectly by engaging BTLA, as opposed to blocking interactions 
with HVEM. These results indicate that the anti-BTLA mAb 
6F7 has agonistic activity that stimulates BTLA-mediated in-
hibitory signals leading to decreased T cell  –  immune responses 
in vitro. 
Therefore, rapid colitis induction in the absence of HVEM 
expression is dominant over the decreased infl  ammation ob-
served when   Light      /        T cells were transferred. 
  The inhibitory HVEM ligand BTLA is expressed by acti-
vated T cells, and therefore interactions between   Rag      /        host 
HVEM and T cell BTLA could alter the acceleration of colitis. 
To test this, we evaluated BTLA expression by naive CD4  +   T 
cells and by CD4  +   T cells after transfer. Consistent with previ-
ous reports (  42  ), we detected BTLA expression on naive and 
activated CD4  +   T lymphocytes. In vitro TCR stimulation en-
hanced BTLA expression on CD4  +   T cells, with the highest 
level of BTLA observed 2  –  3 d after stimulation (  Fig. 6 A  ).   
Likewise, we found BTLA expression on CD4  +   T cells iso-
lated from the spleens, MLNs, and LPLs of transferred   Rag      /        
recipients (  Fig. 6 B  ). Although BTLA expression on LPLs was 
slightly lower than that observed on T cells from the spleens or 
MLNs, this was likely a consequence of the reduced surface 
protein expression caused by the collagenase digestion during 
LPL isolation. Consistent with this, the amount of CD4 was 
    Figure 6.         Minimal effect of T cell BTLA defi  ciency on colitis 
pathogenesis.   (A) BTLA expression on freshly isolated naive CD4  +   T  cells 
and by CD4  +   T cells stimulated in vitro with an anti-CD3     mAb in the 
presence of irradiated T cell  –  depleted splenocytes. (B) BTLA expression on 
transferred CD4  +   T cells isolated from   Hvem    /   Rag   /      recipients 2 wk 
after transfer. Histograms represent BTLA expression by gated CD4  +   TCR-
    +   cells from the indicated sites. (C) Transfer of   Btla    /      CD4 + CD45RB high  
T cells into   Rag    /      recipients. Weight loss curves of   Rag    /      recipients 
transferred with either WT T cells (squares) or   Btla    /      T cells (triangles). 
Data shown represent the average of six to eight mice in each group. 
(D) Histological scores were evaluated 2 (left) or 5 wk (right) after the 
transfer of T cells. Each symbol represents an individual mouse (  n   =  5 – 8). 
Data are representative of four independent experiments. *, P   <   0.05.     JEM VOL. 205, June 9, 2008 
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all the transferred animals presented with severe intestinal in-
fl  ammation and similar histological average scores (  Fig. 8 D  ). 
These results demonstrate that the anti-BTLA mAb prevents 
colitis acceleration when the donor T cells express BTLA. 
Therefore, we conclude that BTLA signaling on T cells me-
diated by HVEM expressed by an irradiation-resistant cell is 
crucial to prevent colitis acceleration. 
  Accelerated colitis in   Btla      /     Rag      /        recipients 
  Although the eff  ect of the agonistic anti-BTLA mAb required 
BTLA expression by T cells, the experiments presented above 
prove only that T cell expression of BTLA is necessary, but 
not suffi   cient, and therefore it remained possible that BTLA 
expression by host cells in the   Rag        /      mice may also be re-
quired for preventing colitis acceleration. To investigate this 
possibility, we used   Btla        /       Rag        /      animals as recipients of 
WT CD4  +  CD45RB  high   T cells. The transfer of T cells into 
  Btla        /       Rag        /      recipients led to faster weight loss (  Fig. 9 A  ).   
Furthermore, histological analysis performed 2 wk after the 
transfer on samples isolated from the large intestine revealed a 
more severe intestinal infl  ammation in   Btla        /       Rag        /      mice 
(  Fig. 9 B ). To determine if disease acceleration in  Btla        /       Rag        /      
mice was comparable to that observed in HVEM-defi  cient 
  We found that the anti-BTLA mAb also has agonistic ac-
tivity in vivo. Injection of the anti-BTLA mAb every 3 d be-
ginning at the time of T cell transfer greatly delayed weight 
loss and disease progression (  Fig. 8 A  ).   Furthermore,   Hvem      /    
Rag      /        recipients treated with the anti-BTLA mAb had 
lower average histological scores (  Fig. 8 B  ). Collectively, these 
results demonstrate that BTLA engagement was required 
to prevent colitis acceleration, and they suggest that the rapid 
development of disease in   Hvem      /     Rag      /        mice is likely to 
be caused by the absence of BTLA signaling. 
  To evaluate if the anti-BTLA mAb prevents colitis by act-
ing on donor T cells, we transferred   Btla        /      CD4  +  CD45RB  high   
T cells into   Hvem        /       Rag        /      recipients that were then treated 
with the anti-BTLA mAb.   Hvem        /       Rag        /      mice transferred 
with   Btla        /      T cells showed faster weight loss regardless of 
treatment with the anti-BTLA mAb (  Fig. 8 C  ). In addition, 
    Figure 7.         Reduced accumulation of   Btla        /      T cells in   Rag      /        
recipients.   Co-transfer of congenic CD45.1  +   and  CD45.2 +    Btla    /     
CD4  + CD45RB high   T cells into   Rag    /      recipients. (A) Representative percent-
ages of CD45.1  +   ( Btla  +/+  ) and CD45.1        ( Btla     /   )  CD4 +   TCR-   +   cells 
in the spleens, MLNs, LPLs, and IELs of   Rag     /     mice analyzed 2 wk after 
T cell transfer. (B) Same as A, but showing absolute numbers of 
CD45.1  +   (squares) and CD45.1        (circles)  CD4 + TCR-   +   T cells. Each symbol 
represents an individual mouse (  n   = 4). *, P   <   0.05. (C) Intracellular 
IFN-     staining of CD4  + TCR-   +   CD45.1 +   (top dot plots) and CD45.1       
(bottom dot plots) T cells isolated from   Rag     /     mice and restimulated ex 
vivo with PMA and ionomycin. Data shown correspond to a single mouse 
in a total of four mice per group and are representative of two indepen-
dent experiments.     
    Figure 8.         Signaling through BTLA prevents colitis acceleration 
in   Hvem      /     Rag      /        recipients.   (A) Weight loss curves of   Hvem    /   Rag   /     
mouse recipients of WT T cells treated with either 100   μ  g anti-BTLA mAb 
(clone 6F7) or IgG1 isotype control twice a week beginning at the time of 
T cell transfer. Data shown represent the average of four mice in each 
group and are representative of two independent experiments. (B) Histo-
logical scoring performed 3 wk after T cell transfer revealed milder intes-
tinal infl  ammation in samples obtained from   Hvem    /   Rag   /      animals 
treated with the anti-BTLA mAb. Each circle represents a single mouse in 
a total of eight mice per group. *, P   <   0.05. (C) Same as A, except that 
  Hvem    /   Rag   /      animals were transferred with   Btla    /      CD4 + CD45RB high  
T cells. (D) Histological analysis 3 wk after transfer revealed equivalent 
intestinal infl  ammation in all transferred   Hvem    /   Rag   /      animals  regard-
less of the treatment with the anti-BTLA mAb. Each circle represents a 
single mouse in a total of fi  ve mice per group.     1472 HVEM  –  BTLA INTERACTION PREVENTS INTESTINAL INFLAMMATION   | Steinberg et al. 
  Hvem      /        mice do not have a dramatic phenotype, however, 
which might refl  ect the balance between the activating and in-
hibitory signals mediated by HVEM. 
  In this report, we analyzed the role of HVEM in intestinal 
infl  ammation induced by the transfer of naive CD4  +   T cells 
into   Rag      /        mice. This experimental system is well suited to 
the analysis of complex networks of receptor  –  ligand inter-
actions because disease development is synchronous and the 
genotypes of the donor T cells and the immune-defi  cient 
host can be independently varied. The most striking fi  nding 
in the work presented here was the dramatic acceleration of 
colitis observed in   Hvem      /     Rag      /        mice transferred with 
WT CD4  +  CD45RB  high   T cells. Clinical signs correlated with 
an extremely fast weight loss and elevated histological scores 
in the colon within 2 wk after T cell transfer. Colitis acceler-
ation in   Hvem      /     Rag      /        recipient mice was characterized by 
a rapid accumulation of activated T cells producing Th1 cy-
tokines and IL-17 in the large intestine of these recipients. 
This suggests that colitis acceleration is probably induced by 
an exacerbated proinfl  ammatory response mediated by CD4  +   
T cells in the large intestine. 
  Because of the surprising acceleration of disease in 
  Hvem      /     Rag      /        mice, we performed experiments to identify 
the critical cell type(s) that must express HVEM. Although 
APCs were considered the most promising candidate, we 
could fi  nd little evidence for a global alteration in APC func-
tion in   Hvem      /        mice, although T cells cultured in vitro 
with   Hvem      /        MLN DCs and a soluble anti-CD3     mAb did 
exhibit a slightly enhanced proliferative response. Surpris-
ingly, transfer experiments using BM chimeric mice revealed 
that HVEM expression on a radioresistant cell population in 
the   Rag      /        animals is most critical for preventing colitis ac-
celeration. Moreover, we found that mouse IECs expressed 
high levels of HVEM. IECs are a main point of contact 
for enteric antigens, and they play a direct role in regulating 
T cell responses to these antigens (  44  ). It has been recently 
shown that IECs may contribute to the maintenance of T cell 
tolerance in the gut by preventing inappropriate activation of 
CD4  +   T cells (  45, 46  ), and they express PD-L1, the ligand for 
the inhibitory receptor programmed cell death 1 (  46  ). Nev-
ertheless, although epithelial cell expression of HVEM is in-
triguing, IEC permeability was not altered in   Hvem      /        mice, 
and these mice were not more susceptible to DSS colitis. 
Therefore, the absence of HVEM does not alter IEC physio-
logical function in the absence of T cell  –  induced infl  amma-
tion, and it remains to be proven that HVEM expression by 
IECs is required to prevent colitis acceleration. A radioresis-
tant, tissue-specifi  c APC expressing CD70, and required for 
the proliferation of mucosal T cells after oral infection, was 
recently identifi  ed (  47  ), and therefore these cells or some 
other radioresistant HVEM-expressing cell type could be 
most responsible for preventing accelerated colitis. Condi-
tional ablation of HVEM expression in diff  erent cell types in 
  Rag      /        mice with a fl  oxed   Hvem   allele ultimately will be re-
quired to identify the cell type(s) that must express this pro-
tein to prevent disease acceleration. 
hosts, WT CD4  +  CD45RB  high   were simultaneously transferred 
into   Btla        /       Rag        /      or   Hvem        /       Rag        /      mice. In the two 
groups of recipients, colitis development was essentially 
equivalent. Although the trend was toward slightly less weight 
loss and less severe histological scores in   Btla        /       Rag        /      mice 
than in   Hvem        /       Rag        /      mice, the diff  erence did not reach 
statistical signifi  cance (  Fig. 9, C and D  ). Similar results were 
obtained when   Btla        /       Rag        /      recipients were transferred with 
  Btla        /      CD4  +  CD45RB  high  , a situation where BTLA was 
absent in both donor and host cells (  Fig. 9, C and D  ). Col-
lectively, these results demonstrate that BTLA expression by 
  Rag        /      host cells also prevents accelerated colitis in the T cell 
transfer model. 
    DISCUSSION   
  HVEM is a unique TNF family receptor because it has the abil-
ity both to transmit positive signals and to induce negative 
signals. Subsets of T cells constitutively express HVEM, and 
therefore it is perhaps not surprising that many of the experi-
ments analyzing the role of HVEM have focused on T lympho-
cytes. HVEM expressed by T cells is a co-stimulatory receptor 
for LIGHT-mediated T cell activation (  8, 9, 18, 22, 25  ). 
Furthermore, recent reports demonstrated that HVEM also 
engages BTLA and inhibits T cell proliferation (  25, 26, 43  ). 
    Figure 9.         Accelerated colitis in   Btla        /       Rag      /        recipients.   (A)  Weight 
loss curves of   Rag    /      (squares) and   Btla    /   Rag   /      (triangles)  recipients 
transferred with 5   ×   10  5   WT T cells. Data correspond to the average of 
four to six mice per group. (B) Combined proximal and distal colon histo-
logical scores were evaluated 2 wk after T cell transfer. Each symbol 
represents an individual mouse from a total of six to seven animals 
per group. (C) Weight loss curves of   Hvem    /   Rag   /      (circles)  and 
  Btla    /   Rag   /      (open triangles) recipients transferred with 5   ×   10  5   WT 
T cells, and   Btla    /   Rag   /      mice transferred with 5   ×   10  5    Btla     /     T  cells 
(fi  lled triangles). Data correspond to the average of four to six mice per 
group and are representative of two independent experiments. (D) Histo-
logical scores performed on samples obtained from two independent 
experiments 2 wk after T cell transfer. Each symbol represents an indi-
vidual mouse from a total of 5  –  11 animals per group. *, P   <   0.05.     JEM VOL. 205, June 9, 2008 
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  During the review of this paper, it was shown in human 
cells that HVEM binds to CD160, a glycophosphatidylinosi-
tol-anchored member of the Ig super family (  50  ). The au-
thors of this report found that the binding of CD160 by 
HVEM delivered inhibitory signals to human CD4  +   T cells, 
leading to reduced T cell activation and cytokine production 
(  50  ). Although it is not known if this interaction takes place 
in mice, we cannot rule out the possibility of an antiinfl  am-
matory role for the HVEM  –  CD160 interaction in the exper-
imental colitis model. Consistent with a possible role for 
CD160, when   Btla        /       Rag        /      mice were transferred with 
CD4  +   T cells, weight loss and histological scores were less 
severe than in   Hvem        /       Rag        /      recipients. Although the dif-
ferences were not statistically signifi  cant, the trend was to-
ward milder disease in   Btla        /       Rag        /      mice. This was also 
observed when   Btla        /       Rag        /      mice were transferred with 
BTLA-defi  cient T cells, a situation where the HVEM  –  BTLA 
interaction is completely ablated. The diff  erence in colitis be-
tween HVEM and BTLA defi  ciency is not very great, how-
ever, suggesting that most of the disease-accelerating eff  ects 
of HVEM defi  ciency are due to interaction with BTLA as 
opposed to the absence of a hypothetical interaction of mouse 
HVEM with CD160. 
  Contrary to our expectations, the transfer of   Btla      /        
CD4  +  CD45RB  high   T cells into   Rag      /        mice did not replicate 
the severe disease phenotype in the   Hvem      /     Rag      /        recipients. 
Surprisingly, we found that there was a signifi  cant reduction in 
the number of T cells in diff  erent lymphoid organs and in the 
large intestine after transfer of   Btla      /        CD4  +   T cells. In accor-
dance with this fi  nding, it has recently been shown that under 
conditions of chronic stimulation in a GVHD model system, 
  Btla      /        T cells did not survive as well and failed to sustain 
GVHD pathology (  32  ). Therefore, decreased T cell survival 
could partially explain the absence of a dramatic colitis acceler-
ation after transfer of  Btla      /        T cells into  Rag      /        mice. It should 
be noted that after transfer of   Btla      /        T cells into   Rag      /        mice, 
HVEM can still induce inhibitory signals by interacting with 
BTLA expressed by host cells. However, when the stromal 
cells cannot deliver the critical antiinfl  ammatory HVEM-me-
diated signals to either the transferred T cells or to   Rag      /        host 
cells, as is the case in   Hvem      /     Rag      /        recipients, accelerated 
disease occurs, even after transfer of   Btla      /        CD4  +   T cells. 
  In summary, HVEM can act as a receptor to enhance im-
mune responses through binding LIGHT and as a ligand to 
suppress immune response by binding BTLA. It is therefore 
not surprising that HVEM plays a dual role in the develop-
ment of colitis. By analyzing   Hvem  -defi  cient mice and cells, 
previous studies and the work presented here indicate that 
the lack of HVEM expression by T cells decreased T cell ac-
tivation and the development of eff  ector functions. The ef-
fects of HVEM defi  ciency are cell type dependent; however, 
the lack of HVEM expression by an irradiation-resistant cell 
type(s) in the immune-defi  cient recipients caused an acceler-
ation of intestinal infl  ammation.   Hvem      /        mice do not spon-
taneously develop colitis, however, and it is likely that in 
immune-competent mice CD4  +  CD25  +   regulatory T cells or 
  Although HVEM is expressed by the transferred T cells (not 
depicted), the absence of HVEM in the donor T lymphocytes 
slightly reduced the severity of colitis development. Therefore, 
HVEM expression by T cells apparently contributed to the en-
hancement of T cell eff  ector function, opposite to the eff  ect of 
HVEM expression by cells in the RAG-defi  cient hosts. By 
binding to the TNF family ligand LIGHT, HVEM mediates 
co-stimulatory signals (  11, 12, 19, 23, 24  ), and it was recently 
shown that the severity of colitis induced by the transfer of 
LIGHT-transgenic MLN cells into   Rag      /        recipients was 
considerably decreased when the MLN cells were obtained 
from   Hvem      /        mice (  6  ). The authors concluded that HVEM 
expression on T cells is necessary for optimal LIGHT-mediated 
T cell activation and expansion in this system (  6  ). Therefore, T 
cell  –  derived LIGHT interacting with HVEM expressed by the 
same or an adjacent T cell may be required for the full Th1 
and/or Th17 diff  erentiation of gut-homing eff  ector T cells (  4  ). 
Evidence suggesting a potential for T  –  T interactions between 
LIGHT and HVEM on donor T cells also has been developed in 
a GVHD model system (  48  ). Consistent with the co-stimulatory 
role of LIGHT, we found that mice transferred with   Light      /        
CD4  +  CD45RB  high   T cells also had lower histological scores. It is 
noteworthy that if the eff  ect of HVEM defi  ciency in the RAG-
defi  cient host were mediated predominantly by interactions with 
T cell  –  expressed LIGHT, colitis should have been accelerated, 
rather than delayed, after transfer of   Light      /        CD4  +  CD45RB  high   
T cells. When either   Light      /        or   Hvem      /        CD4  +  CD45RB  high   T 
cells were transferred into   Hvem      /     Rag      /        animals, however, 
the disease-accelerating eff  ects of the absence of HVEM in 
the   Rag      /        host were dominant over the more subtle disease-
delaying eff  ects when these molecules were not expressed by the 
gene-defi  cient donor T cells. Therefore, the predominant eff  ect 
of HVEM in this colitis model system is antiinfl  ammatory, and it 
is related to its expression by radiation-resistant innate cells in the 
  Rag      /        hosts. 
  Because BTLA is an inhibitory receptor for T cells, it was 
a good candidate for mediating the antiinfl  ammatory eff  ect of 
HVEM expression in the   Rag      /        recipients. Consistent with 
this hypothesis, treatment of   Hvem      /     Rag      /        recipients of 
CD4  +  CD45RB  high   T cells with an anti-BTLA mAb with ago-
nistic properties was able to reverse the accelerated colitis, but 
only when the T cells expressed BTLA. Although our data 
clearly demonstrate that a major function of the anti-BTLA 
mAb is to attenuate T cell responses, BTLA expression by host 
cells is also relevant. The transfer of WT T cells into BTLA-
defi  cient   Rag        /      recipients also led to accelerated colitis, indi-
cating that T cell expression of BTLA is necessary but not 
suffi   cient, and that there also is a function for BTLA expression 
by host cells in preventing colitis acceleration. BTLA ex-
pression has been detected on myeloid and lymphoid cells, in-
cluding CD11c  +   DCs, a subpopulation of CD11b  +   macrophages 
and also DX5  +   NK cells (  27, 42  ). Interestingly, NK cells have 
been shown to prevent accelerated colitis development in the 
T cell transfer model of colitis (  49  ). Therefore, engagement of 
BTLA on one or more of these innate immune cell types could 
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ferred mice were monitored regularly for signs of disease, including weight 
loss, hunched over appearance, piloerection of the coat, and diarrhea. For 
cotransfer experiments, CD4  +  CD45RB  high   T cells were isolated from con-
genic CD45.1  +   and CD45.2  +     Btla        /      mice, mixed in equal numbers and in-
jected i.v. into   Rag        /      recipients. 
  Preparation of IELs and LPLs.     Mucosal lymphocytes were isolated and 
prepared as described previously (  34  ). In brief, the large intestine was re-
moved and placed in chilled HBSS media containing 5% FCS. The intestines 
were carefully cleaned from their mesenteries and fl  ushed of fecal content. 
Intestines were opened longitudinally and cut into 1-cm pieces. The intesti-
nal tissue was transferred to 250-ml Erlenmeyer fl  asks containing 25 ml of 
preheated HBSS supplemented with 2% FBS and 1 mM DTT (Sigma-
Aldrich) and shaken at 200 rpm for 40 min at 37  °  C. The tissue suspensions 
were passed through a stainless steal sieve into 50-ml conical tubes, and the 
cells were pelleted by centrifugation at 1,200 rpm for 10 min at 4  °  C. The 
cell pellets were resuspended in complete HBSS, layered over a discontinu-
ous 40/70% Percoll (GE Healthcare) gradient, and centrifuged at 2,000 rpm 
for 30 min. Cells from the 40/70% interface were collected, washed, and re-
suspended in complete RPMI media (Invitrogen). These purifi  ed cells con-
stituted the IEL population. To isolate LPLs, the remaining intestinal tissue 
in the stainless steal sieve was minced and transferred to conical tubes. The 
minced pieces were resuspended in 20 ml of complete RPMI containing 
1 mg/ml of type IV collagenase (Sigma-Aldrich) and shaken at 200 rpm for 
40 min at 37  °  C. The tissue suspension was collected and passed through a 
70-  μ  m cell strainer, and then the cells were pelleted by centrifugation at 
1,200 rpm. The cells were then resuspended and layered onto a 40/70% 
Percoll gradient, centrifuged, and processed as described above for the 
IEL preparation. 
  Histology.     At various time points after cell transfer, animals were killed for 
histological analysis. Tissue samples of 3  –  5 mm obtained from distal and 
proximal portions of the large intestine were fi  xed in 4% formalin. Fixed tis-
sues were later embedded in paraffi   n and 3-  μ  m sections were prepared and 
stained with H  &  E. To evaluate the severity of the infl  ammation, samples 
were coded and scored by a pathologist in a blinded fashion using a previ-
ously described scoring system (  34  ). Scores from the two parts of the intes-
tine were averaged to represent the severity of disease. Higher scores 
(maximum 14) indicate greater pathology. Categories scored are the follow-
ing: degree of infl  ammatory cell infi  ltrate in the lamina propria, goblet cell 
depletion, epithelial cell reactive atypia/hyperplasia, number of IELs in epi-
thelial crypts, and number of infl  ammatory foci. 
  Flow cytometry analysis.     Spleens and MLNs were removed and then 
mashed through a 70-  μ  m cell strainer, and red blood cells in the cell suspen-
sion were removed using a lysing buff  er (Sigma-Aldrich). IELs and LPLs 
were isolated as described above. Before staining, cells were washed and re-
suspended in staining buff  er containing 1  ×   PBS, 2% BSA, 10 mM EDTA, 
and 0.01 NaN  3  . To block nonspecifi  c staining, anti-CD16/32 antibody 
was added. Antibodies for cell surface markers were added, and cells were 
incubated for 20 min on ice. After staining, the cells were washed twice 
with staining buff  er, analyzed the same day or fi  xed in PBS containing 
1% paraformaldehyde and 0.01 NaN  3  , and analyzed later in a FACSCalibur 
(BD Biosciences). 
  Detection of cytokines by ELISA.     2 wk after the transfer of 
CD4  +  CD45RB  high   T cells, LPLs were isolated from the recipients and 10  6   
cells were cultured in RPMI complete medium in the presence of PMA and 
ionomycin for 48 h. The amounts of IFN-    , IL-4, TNF, and IL-2 in the 
culture supernatants were quantifi  ed by ELISA. Antibodies and recombinant 
cytokine standards were purchased from BD Biosciences. 
  RNA isolation and real-time PCR.     2 wk after the transfer of 
CD4  +  CD45RB  high   T cells, 1.5 cm from the large intestines of the recipients 
was removed and resuspended in TRIZol (Invitrogen). The samples were 
other mechanisms prevent gut infl  ammation. Moreover, the 
counterbalancing eff  ects of HVEM expression by diff  erent 
cell types, and the dual engagement of proinfl  ammatory 
LIGHT and antiinfl  ammatory BTLA by HVEM, may ex-
plain the absence of spontaneous colitis in   Hvem      /        mice. 
Our fi  ndings therefore depended critically on the power of 
the T cell transfer model of colitis in analyzing cell  –  cell inter-
actions and the interplay of the innate adaptive immune systems, 
as we could separate the proinfl  ammatory and antiinfl  amma-
tory eff  ects of HVEM expression by comparing   Hvem      /        T cell 
donors and   Hvem      /     Rag      /        recipients to their WT counter-
parts. Although the majority of studies on HVEM have ad-
dressed the participation of this molecule when expressed by 
T cells or APCs, our studies demonstrate the unexpected and 
important role that this molecule plays to prevent infl  ammation 
when expressed by irradiation-resistant nonlymphoid cells. 
The expression of HVEM and BTLA on both innate and 
adaptive cells, along with the fi  ndings presented here, suggest 
that this ligand  –  receptor system could play diverse roles in 
immunity and infl  ammation in both the innate and adaptive 
immune systems that have yet to be fully elucidated. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6,   Rag      /        (C57BL/6 background), and C57BL/6-SJL 
CD45.1 congenic mice were purchased from The Jackson Laboratory and 
maintained in our facility.   Btla      /        (  28  ),   Light      /        (  37  ), and   Hvem      /        mice 
(  26  ) have been described previously. All gene-defi  cient mice were back-
crossed for at least six generations onto the C57BL/6 background.   Hvem      /        or 
  Btla      /        mice were crossed to   Rag      /        mice to generate   Hvem      /     Rag      /        and 
  Btla      /     Rag      /        recipient animals, respectively. Mice were maintained at the 
La Jolla Institute for Allergy and Immunology under specifi  c pathogen-free 
conditions, and sentinels from the mouse colony tested negative by PCR 
detection of   Helicobacter spp  . and   Citrobacter rodentium  . Mice were used at 
7  –  12 wk of age. Animal care and experimentation were consistent with the 
National Institutes of Health guidelines and were approved by the Institu-
tional Animal Care and Use Committee at the La Jolla Institute for Allergy 
and Immunology. 
  Antibodies and reagents.     The following mouse antibodies were pur-
chased from BD Biosciences as conjugated to FITC, PE, PE-Cy5, PerCP-
Cy5.5, or allophycocyanin: CD4 (L3T4), CD45RB (16A), CD45.2 
(104), TCR      chain (H57-597), and rat anti  –  hamster IgG (cocktail). 
A PE-conjugated and purified anti  –  mouse BTLA mAb (6F7) were 
purchased from eBioscience and Bio Express, Inc., respectively. Anti  –
  mouse HVEM antibody (  26  ) was provided by Y.X. Fu (University of 
Chicago, Chicago, IL). Anti  –  mouse CD16/32 used for Fc receptor block-
ing was purifi  ed in our laboratory. Purifi  ed mouse IgG1 was purchased 
from Millipore. 
  CD4  +   CD45RB  high   T cell isolation and transfers.     Spleens were re-
moved from the donor mice (C57BL/6,   Light      /       ,   Hvem      /       ,   Btla      /       , or B6-
SJL CD45 congenic) and teased into cell-single suspensions in HBSS media 
(Invitrogen). Cell suspensions were fi  ltered through a 70-  μ  m cell strainer 
(Thermo Fisher Scientifi  c), and then CD4  +   cells were enriched by positive 
selection using anti-CD4 (L3T4) microbeads according to the manufactur-
er  ’  s protocol (Miltenyi Biotec). The CD4  +  -enriched cells were washed 
twice and stained with PE-Cy5  –  conjugated anti-CD4 and PE-conjugated 
anti-CD45RB antibodies. After staining, the cells were washed, and the 
CD4  +  CD45RB  high   T cell population was sorted by fl  ow cytometry using a 
FACS-DIVA cell sorter (Becton Dickinson). Purifi  ed CD4  +  CD45RB  high   
naive T cells were washed twice and resuspended in PBS, and 5   ×   10  5   cells 
in 200   μ  l of PBS were injected i.v. into the diff  erent recipient mice. Trans-JEM VOL. 205, June 9, 2008 
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then frozen at     80  °  C. For RNA isolation, the whole tissue was homoge-
nized, DNA and proteins were removed by precipitation with chloroform, 
and RNA was extracted with isopropanol. cDNA was synthesized from the 
total RNA using the Superscript II system (Invitrogen) according to the 
manufacturer  ’  s instructions. Subsequently, the cDNA was subject to real-
time PCR using SYBR green (Bio-Rad Laboratories) and the following 
mouse primers: TNF forward, 5    -CATCTTCTCAAAATTCGAGT-
GACAA-3    ; TNF reverse, 5    -TGGGAGTAGACAAGGTACAACCC-3    ; 
IFN-     forward, 5    -TCAAGTGGCATAGATGTGGAAGAA-3    ; IFN-     
reverse, 5    -TGGCT  CTGCAGGATTTTCATG-3    ; IL-4 forward, 5    -
ACAGGAGAAGGGACGCCAT-3    ; IL-4 reverse, 5    -GAAGCCCTA-
CAGACGAGCTCA-3    ; IL-17 forward, 5    -GGTCAACCTCAAAGTCTT-
TAACTC-3    ; IL-17 reverse, 5    -TTAAAAATGCAAGTAAGTTTGCTG-
3    ; IL-12p35 forward, 5   -TGAAGACGGCCAGAGAAAAAC-3    ; IL-12p35 
reverse, 5    -AAGGAACCCTTAGAGTGCTTACT-3    ; IL-23p19 forward, 
5    -AGC  GGGACATATGAATCTACTAAGAGA  -3    ; IL-23p19 reverse, 
5    -GTCCTAGTAGGGAGGTGTGAAGTTG-3    ; IL-10 forward, 5    -
GGTTGCCAAGCCTTATCGGA-3    ; IL-10 reverse, 5    -ACCTGCTC-
CACTGCCTTGCT-3    ; TGF-     forward, 5    -TGACGTCACTGGAGTT-
GTACGG-3    ; TGF-     reverse, 5    -GGTTCATGTCATGGATGGTGC-3    ; 
L32 forward, 5    -GAAACTGGCGGAAACCCA-3    ; and L32 reverse, 
5    -GGATCTGGCCCTTGAACCTT-3    . Gene expression was normalized to 
L32. Data were collected and analyzed on an iCycler (Bio-Rad Laboratories). 
  Generation of BM chimeras.       Rag        /      or   Hvem        /       Rag        /      hosts were 
lethally irradiated with 11 Gy that were applied in two irradiations of 5.5 Gy 
separated by a 3-h interval. After irradiation,   Hvem      /     Rag      /        hosts were trans-
planted with 5   ×   10  6   total BM cells isolated from   Rag      /        mice to generate 
  Rag      /         →    Hvem      /     Rag      /        chimeric animals. Reciprocal   Hvem      /     Rag      /         →
    Rag      /        chimeras were generated by transplanting   Hvem      /     Rag      /        BM cells 
into irradiated   Rag      /        hosts. After transplant, mice were maintained under an-
tibiotic treatment for 4 wk and an additional 6 wk without antibiotic before 
transfer of the CD4  +  CD45RB  high   T cells. 
  Statistics.     Diff  erences between groups were evaluated for statistical signifi  -
cance by the two-tailed unpaired Student  ’  s   t   test, except for histological 
scoring that was evaluated using Wilcoxon  ’  s two-group test. Results are ex-
pressed as mean   ±   SD. p-values of   <  0.05 were considered signifi  cant. 
  Online supplemental material.     Fig. S1 (A and B) shows, respectively, the 
phenotype of freshly isolated or LPS-stimulated CD11c  +   cells isolated from 
the MLNs of WT or   Hvem        /      mice. Fig. S1 C shows proliferation assessed 
by CFSE dilution of CD4  +  CD25        T cells cultured with WT or   Hvem        /      
CD11c  +   and an anti-CD3     mAb. Fig. S2 A shows HVEM expression on 
purifi  ed primary colonic epithelial cells. Fig. S2 B shows the results from in-
testinal permeability experiments performed on distal colons isolated from 
untreated WT and   Hvem        /      mice or WT animals treated with 4% DSS. Fig. 
S3 (A and B) shows, respectively, weight loss curves and histological scores 
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